Ipsos SA Due Diligence
Run due diligence on Ipsos SA: check compliance and get alerts when suppliers or ownership change.
France · owned by Independent (France) · ipsos.com · 7 vendors
Ipsos is one of the world's leading market research and public opinion specialist companies, operating across 90 markets with over 20,000 employees. The company delivers reliable data and insights through surveys, polls, social media analysis, and qualitative research to help clients understand society, markets, and people. Ipsos serves more than 5,000 clients globally, providing actionable insights into the experiences and opinions of citizens, consumers, patients, customers, and employees.
Resilience scores
- Digital Sovereignty: 29
- Digital Resilience: 9
- Financial Resilience: 8
Technology vendors
- Cloudflare, Inc. — Technology — United States
- Google LLC — Technology — United States
- OneTrust — Technology — United States
- and 4 more
Insights
Last updated 2026-11-22 · revision 2
7 direct vendors, 126 subvendors
Direct vendors by controlling owner country (sample)
- United States: 5
- Belgium: 1
- Sweden: 1
Subvendors by controlling owner country (sample)
- Romania: 1
- Norway: 1
- India: 1
Compliance
10 in-scope frameworks identified; showing 3.
French Anti-Gift Law — No public evidence
As a company conducting healthcare market research in France, which involves interactions with healthcare professionals, Ipsos's activities could fall under the scope of this law regulating benefits offered to healthcare professionals.
ISO 27001 (source) — Evidence found
As a company handling large volumes of client and respondent data, information security is critical. ISO 27001 certification is a widely recognized standard for information security management expected by many corporate clients.
Evidence: https://www.ipsos.com/en-ro/quality-and-transparency, https://www.ipsos.com/en-be/topic/security, https://www.ipsos.com/en-be/ipsos-belgium-achieves-iso-27001-certification-strengthening-trust-research-data-security, https://www.bureauveritas.es/recursos/actualidad/certificado-ipsos-iso-27001, https://www.ipsosbanda.ie/certifications/
ISAE 3000 (source) — No public evidence
Similar to SOC 2, an ISAE 3000 report can provide independent assurance over non-financial information, such as controls over data privacy or security, which would be relevant to Ipsos's services and its clients' due diligence.
Financials
Three-year financials
- 2025: revenue €2,524.7M, EBIT €309M, equity €1,577M
- 2024: revenue €2,440.8M, EBIT €319.7M, equity €1,578M
- 2023: revenue €2,389.8M, EBIT €312.4M, equity €1,433M
Financial Resilience Score: 8/10
Ipsos SA demonstrates strong financial resilience, supported by consistently high operating margins (13.1% in 2023 and 2024, 12.3% in 2025 or 12.8% at constant scope), robust cash generation (€411m operating cash flow in 2025 vs €430m in 2024), and a healthy balance sheet with equity of ~€1.58bn and low net debt (€220m at H1 2026, down from €251m a year earlier). The Group benefits from significant geographic diversification across EMEA (49%), Americas (35%), and Asia-Pacific (16%), as well as sectoral diversification across Consumers, Clients and employees, Citizens, and Doctors and patients segments. The company has maintained profitability across cycles and continues to execute an active M&A strategy, with recent acquisitions (BVA Family, infas) adding 5.8% to 2025 revenue. However, resilience is tempered by meaningful risks: organic growth has slowed to 0.6% in 2025 (below management's ambitions), FX exposure has pressured reported revenue, and Public Affairs activity has been hurt by tighter government budgets. Non-recurring costs of €19m in H1 2026 (including €11m in IT project impairments) and gross margin dilution of 70bps from integrations highlight ongoing operational challenges. The launch of the 'Horizons' strategic plan and new CEO leadership (Jean Laurent Poitou, September 2025) add execution risk but also potential upside.
Key strengths: Operating margin maintained at 12-13% range through cycles, Strong operating cash flow (€411m in 2025), Low leverage with net debt of only €220m at H1 2026, Geographic diversification across 90 markets, Sectoral diversification across Consumers, Citizens, Clients, Doctors/Patients, Active and accretive M&A strategy (BVA, infas), Equity base of ~€1.58bn provides balance sheet strength
Risk factors: Organic growth slowing to 0.6% in 2025, below management ambitions, FX headwinds (3.0% negative impact in 2025), Public Affairs weakness due to tighter government budgets globally, Margin dilution from recent acquisitions (70bps gross margin decline in H1 2026), €19m non-recurring costs in H1 2026 including IT project impairments, Client wait-and-see attitude amid geopolitical uncertainty, CEO transition and new 'Horizons' strategic plan execution risk
Revenue by geography
- EMEA: 49%
- Americas: 35%
- Asia-Pacific: 16%
Revenue by product/service
- Consumers: 49%
- Clients and employees: 21%
- Citizens: 15%
- Doctors and patients: 15%
Signed-in users can see whether their own company is exposed to this vendor's disruption, plus the full sub-vendor list and country breakdowns, every in-scope compliance framework plus gaps and next steps, and alerts when any of it changes.